Nasal Drug Delivery Systems Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Nasal Drug Delivery Systems Market to 2027 - Global Analysis and Forecasts by Containers (Pressurized Containers and Non-Pressurized Containers), Type (Nasal Drops, Nasal Sprays, Nasal Gels and Others), Application (Nasal Congestion, Allergy, Vaccination, Rhinitis and Others) and Geography

Report Code: TIPRE00003139 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Nasal drug delivery is administering drug through nasal route, it is an alternative to invasive administration. The nasal drug delivery provides direct access to the systemic circulation. The advantages of the nasal drug delivery includes rapid drug absorption, fact relief, and non-invasive route among the others.

The nasal drug delivery systems market is expected to grow in the forecast period owing to driving factors such as rise in the prevalence of the asthma, respiratory diseases, increasing number of common cold and cough and others. The market players is likely to experience the growth opportunities in the emerging nations due to the technological advancements and innovative innovations for the drug delivery systems.

The "Global Nasal Drug Delivery Systems Market Analysis to 2027" is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global nasal drug delivery systems market with detailed market segmentation by containers, type, application, and geography. The global nasal drug delivery systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nasal drug delivery systems market players and offers key trends and opportunities in the market.

The global nasal drug delivery systems market is segmented on the basis of containers, type, and application. Based containers, the market is segmented as pressurized containers and non-pressurized containers. On the basis of the type the segments is classified as nasal drops, nasal sprays, nasal gels and others. On the basis of the application the market segmentation is classified as nasal congestion, allergy, vaccination, rhinitis and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global nasal drug delivery systems market based on containers, type and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nasal drug delivery systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the nasal drug delivery systems market in the forecast period. Asia Pacific is anticipated to be the fastest growing region due to the increase in the cases of asthma, respiratory diseases, and viral infections that causes cold and flu.

The report analyzes factors affecting nasal drug delivery systems market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nasal drug delivery systems market in these regions.

The report also includes the profiles of key nasal drug delivery systems market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the nasal drug delivery systems market include, 3M, OptiNose US, Inc., AptarGroup, Inc., BD, GlaxoSmithKline plc., AstraZeneca, Merck & Co., Inc., Pfizer Inc, B.F. Ascher & Company, Inc. and Neurelis, Inc.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Nasal Drug Delivery Systems Market- By Containers
1.3.2. Nasal Drug Delivery Systems Market- By Type
1.3.3. Nasal Drug Delivery Systems Market- By Application
1.3.4. Nasal Drug Delivery Systems Market- By Region
1.3.4.1. By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NONINVASIVE PRENATAL DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. NASAL DRUG DELIVERY SYSTEMS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NASAL DRUG DELIVERY SYSTEMS MARKET- GLOBAL ANALYSIS
6.1. NASAL DRUG DELIVERY SYSTEMS MARKET - GLOBAL MARKET OVERVIEW
6.2. NASAL DRUG DELIVERY SYSTEMS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - CONTAINERS
7.1. OVERVIEW
7.2. CONTAINERS MARKET FORECASTS AND ANALYSIS
7.3. PRESSURIZED CONTAINERS MARKET
7.3.1. Overview
7.3.2. Pressurized Containers Market Forecast and Analysis (US$ Mn)
7.4. UN-PRESSURIZED CONATINERS MARKET
7.4.1. Overview
7.4.2. Un-Pressurized Containers Forecast and Analysis (US$ Mn)

8. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. NASAL DROPS MARKET
8.3.1. Overview
8.3.2. Nasal Drops Market Forecast and Analysis (US$ Mn)
8.4. NASAL SPRAYS MARKET
8.4.1. Overview
8.4.2. Nasal Sprays Market Forecast and Analysis (US$ Mn)
8.5. NASAL GELS MARKET
8.5.1. Overview
8.5.2. Nasal Gels Market Forecast and Analysis (US$ Mn)
8.6. OTHERS MARKET
8.6.1. Overview
8.6.2. Others Modelling Market Forecast and Analysis (US$ Mn)

9. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. NASAL CONGESTION MARKET
9.3.1. Overview
9.3.2. Nasal Congestion Market Forecast and Analysis (US$ Mn)
9.4. ALLERGRY MARKET
9.4.1. Overview
9.4.2. Allergy Market Forecast and Analysis (US$ Mn)
9.5. VACCINATION MARKET
9.5.1. Overview
9.5.2. Vaccination Market Forecast and Analysis (US$ Mn)
9.6. RHINITIS MARKET
9.6.1. Overview
9.6.2. Rhinitis Market Forecast and Analysis (US$ Mn)
9.7. OTHERS MARKET
9.7.1. Overview
9.7.2. Others Modelling Market Forecast and Analysis (US$ Mn)
?
10. NASAL DRUG DELIVERY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA NASAL DRUG DELIVERY SYSTEMS MARKET
10.1.1. North America Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.3. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.4. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.1.5. North America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.6.2. US Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.6.3. US Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.7.2. Canada Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.7.3. Canada Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.1.8.2. Mexico Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.1.8.3. Mexico Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2. EUROPE NASAL DRUG DELIVERY SYSTEMS MARKET
10.2.1. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.3. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.4. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.5. Europe Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.6.2. UK Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.6.3. UK Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.7.2. Germany Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.7.3. Germany Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.8.2. France Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.8.3. France Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.9.2. Italy Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.9.3. Italy Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.2.10.2. Spain Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.2.10.3. Spain Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3. ASIA PACIFIC NASAL DRUG DELIVERY SYSTEMS MARKET
10.3.1. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.3. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.4. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.5. Asia Pacific Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.6.2. Japan Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.6.3. Japan Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7. India Market Overview
10.3.7.1. India Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.7.2. India Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.7.3. India Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8. China Market Overview
10.3.8.1. China Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.8.2. China Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.8.3. China Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.9.2. South Korea Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.9.3. South Korea Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.3.10.2. Australia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.3.10.3. Australia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) NASAL DRUG DELIVERY SYSTEMS MARKET
10.4.1. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.3. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.4. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4.5. Middle East & Africa (MEA) Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.6.2. South Africa Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.6.3. South Africa Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.7.2. Saudi Arabia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.7.3. Saudi Arabia Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.4.8.2. UAE Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.4.8.3. UAE Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA NASAL DRUG DELIVERY SYSTEMS MARKET
10.5.1. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.5.3. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.5.4. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.5.5. South and Central America Nasal Drug Delivery Systems Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.5.6.2. Brazil Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.5.6.3. Brazil Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Nasal Drug Delivery Systems Market Forecasts and Analysis - By Containers (US$ Mn)
10.5.7.2. Argentina Nasal Drug Delivery Systems Market Forecasts and Analysis - By Type (US$ Mn)
10.5.7.3. Argentina Nasal Drug Delivery Systems Market Forecasts and Analysis - By Application (US$ Mn)

11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions

12. NASAL DRUG DELIVERY SYSTEMS MARKET, KEY COMPANY PROFILES
12.1. 3M
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product/Service Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. OPTINOSE US, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product/Service Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. APTARGROUP, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product/Service Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product/Service Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLASOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product/Service Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product/Service Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MERCK & CO., INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product/Service Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product/Service Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. B.F. ASCHER & COMPANY, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product/Service Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NEURELIS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product/Service Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments
?
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

NOTE:
• This ToC is tentative in nature and is subject to further refinement during the course of the research study
• The list of company profiles included in this ToC is tentative. Profiles of specific players, if required, shall be added to the report upon request.
• Financials can be provided to the extent of availability in the public domain.
The List of Companies

1. 3M
2. OptiNose US, Inc.
3. AptarGroup, Inc.
4. BD
5. GlaxoSmithKline plc.
6. AstraZeneca
7. Merck & Co., Inc.
8. Pfizer Inc
9. B.F. Ascher & Company, Inc.
10. Neurelis, Inc.